TEL AVIV, ISRAEL — (Marketwired) — Oct 25, 2017 — InspireMD (NYSE MKT:NSPR) (NYSE MKT: NSPR.WS) (NYSE American: NSPR) (NYSE American: NSPR.WS), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that Prof. Waclaw Kuczmik, Head of the Vascular Surgery Department of Katowice Clinical Hospital N […]
Other News
Novoheart Strengthens North American Presence Opening New R&D Location at the World-class Cove Facility, UC Irvine, California
IRVINE, CALIFORNIA — (Marketwired) — Oct 25, 2017 — Novoheart (“Novoheart” or the “Company”) (TSX VENTURE: NVH), a global stem cell biotechnology company, is pleased to announce that it has opened a new US location in The Cove at UC Irvine, California. The Cove is home to UCI Applied Innovation – a public-private […]
ROX Medical Announces Sustained Improvements in Patients With Uncontrolled Hypertension Treated With the ROX Coupler
SAN CLEMENTE, Calif., Oct. 26, 2017 /PRNewswire/ — Rox Medical Inc., a privately held medical device company pioneering an innovative interventional vascular therapy for uncontrolled hypertension, announced the publication of 12-month outcomes of the ROX CONTROL HTN study in the prestigious journal, Hypertension. CONTROL HTN is a multi-center randomized controlled trial that […]
BioTrace Medical Announces Key Events Featuring Tempo® Temporary Pacing Lead at TCT 2017
SAN CARLOS, Calif.–(BUSINESS WIRE)–BioTrace Medical, Inc., today announced the company’s key activities at the Transcatheter Cardiovascular Therapeutics (TCT) 2017 meeting, which will take place October 29 – November 2 at the Colorado Convention Center in Denver. The company’s Tempo® Temporary Pacing Lead will be featured in a breakfast symposium titled: “The […]
Boston Scientific Announces Results For Third Quarter 2017
MARLBOROUGH, Mass., Oct. 26, 2017 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated sales of $2.222 billion during the third quarter ended September 30, 2017. This represents growth of 5.6 percent on a reported basis and 5.7 percent on an operational basis (excludes the impact of changes in foreign currency exchange rates), all compared to the […]
Gore Recognized as one of the World’s Best Workplaces by Great Place to Work®
NEWARK, Del., Oct. 26, 2017 /PRNewswire/ — More than 10 million people from 6,600 companies participated in the survey process for the World’s Best Workplaces list, sharing their perspectives on their work environment. And for the sixth consecutive year, W. L. Gore & Associates is among just 25 companies to earn a spot on the […]
CorInnova Awarded Seminal Patent for Minimally Invasively-Delivered Soft Robotic Heart Device to Support Heart Function
HOUSTON–(BUSINESS WIRE)–October 26, 2017– CorInnova Inc., an emerging medical device company developing novel technology for the treatment of Heart Failure, announced today three milestone events: (1) the Company has received notice of allowance of a seminal patent to protect its intellectual property associated with the world’s first minimally invasively-delivered soft robotic […]
Bard Announces Third Quarter Results And Supplemental Financial Data
MURRAY HILL, N.J.–(BUSINESS WIRE)– C.R. Bard (NYSE: BCR) today reported 2017 third quarter financial results. The company has included supplemental financial data on its website related to this earnings release. Third quarter 2017 net sales were $989.8 million, an increase of 5 percent over the prior-year period on an as-reported basis. Excluding the […]
Cardiovascular Systems, Inc. Reports Fiscal 2018 First-Quarter Financial Results
ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (NASDAQ: CSII): Conference Call Scheduled for Today, October 25, 2017, at 3:45 PM CT (4:45 PM ET) Revenues of $49.7 million were flat versus first quarter last year Gross margin increased to 81.5% from 81.0% in the prior-year period Net loss was $(2.0) […]
CeloNova’s COBRA PzF NanoCoated Coronary Stent Being Studied with 14-day DAPT in High Bleeding Risk Patien
SAN ANTONIO, Oct. 26, 2017 /PRNewswire/ — CeloNova BioSciences, a global medical device company that offers a family of innovative products based upon its proprietary Polyzene™-F nanocoating technology, today announced that the U.S. Federal Drug Administration (FDA) approved expansion of CeloNova’s ongoing clinical trial of its proprietary COBRA PzF™ NanoCoated Coronary […]



